EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology

Qiaoran Qi iD, Dai Su iD, Shuqin Zhuang iD, Sunyuan Yao, Ludwig M Heindl, Xianqun Fan iD, Ming Lin, Jin Li iD, Yan Pang iD

Advanced Science · 2025-02 · 12 (6)

DOI: 10.1002/advs.202407340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 04.01.2025. Verfasst von Qiaoran Qi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Hauptthemen laut MEDLINE: Nanotechnology, Drug Delivery Systems, Ophthalmology, Burns, Chemical. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 368 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Foundation for Translational Medicine's National Infrastructures, Innovative Research Team of High-level Local University in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular surface chemical injuries often result in permanent visual impairment and necessitate complex, long‐term treatments. Immediate and extensive irrigation serves as the first‐line intervention, followed by various therapeutic protocols applied throughout different stages of the condition. To optimize outcomes, conventional regimens increasingly incorporate biological agents and surgical techniques. In recent years, nanotechnology has made significant strides, revolutionizing the management of ocular surface chemical injuries by enabling sustained drug release, enhancing treatment efficacy, and minimizing side effects. This review provides a comprehensive analysis of the etiology, epidemiology, classification, and conventional therapies for ocular chemical burns, with a special focus on nanotechnology‐based drug delivery systems in managing ocular surface chemical injuries. Twelve categories of nanocarrier platforms are examined, including liposomes, nanoemulsions, nanomicelles, nanowafers, nanostructured lipid carriers, nanoparticles, hydrogels, dendrimers, nanocomplexes, nanofibers, nanozymes, and nanocomposite materials, highlighting their advantages in targeted delivery, biocompatibility, and improved healing efficacy. Additionally, current challenges and limitations in the field are discussed and the future potential of nanotechnology in treating ocular diseases is explored. This review presents the most extensive examination of this topic to date, aiming to link recent advancements with broader therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanotechnologyDrug Delivery SystemsOphthalmologyBurns, ChemicalEye BurnsHumansAnimals

Stichwörter der Autor:innen

drug deliverynanotechnologyocular surface chemical injurytherapy

Autor:innen und Institutionen

  • Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
  • Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Center for Basic Medical Research and Innovation in Visual System Diseases, Ministry of Education, Shanghai, 200011, China.
  • Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.
  • Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Cologne, Germany.
  • Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China.

ORCID-Profile: Qiaoran Qi, Dai Su, Shuqin Zhuang, Xianqun Fan, Jin Li, Yan Pang

Förderung

  • National Natural Science Foundation of China
  • Shanghai Foundation for Translational Medicine's National Infrastructures
  • Innovative Research Team of High-level Local University in Shanghai
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Eye Disease Research Center's Key Clinical Specialty
  • China Scholarship Council

Zitieren

APA

Qi, Q., Su, D., Zhuang, S., Yao, S., Heindl, L. M., Fan, X., Lin, M., Li, J., & Pang, Y. (2025). Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology. Advanced Science, 12(6). https://doi.org/10.1002/advs.202407340

Vancouver

Qi Q, Su D, Zhuang S, Yao S, Heindl LM, Fan X, et al. Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology. Advanced Science. 2025;12(6). doi:10.1002/advs.202407340

BibTeX
@article{Qi2025,
  author = {Qi, Qiaoran and Su, Dai and Zhuang, Shuqin and Yao, Sunyuan and Heindl, Ludwig M and Fan, Xianqun and Lin, Ming and Li, Jin and Pang, Yan},
  title = {Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {6},
  doi = {10.1002/advs.202407340}
}
Kostenlos starten →